The table below summarizes total stock grants made at each grant date as of June 30, 2026 with a vesting date after January 1, 2025.


Grant Date	Class of common stock granted	Total number of shares granted		Grant Date Fair Value Per Share		Total Fair Value of Grant		Vesting Date
3/19/2024	Class I		2,387	$	25.01	$	60	3/19/2025
8/1/2024	Class I		3,335	$	24.89	$	83	8/1/2025
8/1/2025	Class I		3,548	$	23.39	$	83	8/1/2026
1/6/2026	Class I		1,172	$	23.15	$	27	1/6/2027

Under the Company’s amended and restated independent director compensation plan (the “DCP”), restricted shares generally vest over a one-year period from the date of the grant, subject to the specific terms of the grant. Restricted shares are included in common stock outstanding on the date of grant. Compensation expense associated with the restricted shares issued under the DCP was $18 and $45 for the three and six months ended June 30, 2026, respectively. As of June 30, 2026, the Company had $20 of unrecognized compensation expense related to the restricted shares issued, in the aggregate. The weighted average remaining period that unrecognized compensation expense related to such shares will be recognized is 0.4 years. There were no restricted shares that vested during the three and six months ended June 30, 2026. The total fair value at the vesting date for restricted shares that vested during the three and six months ended June 30, 2025 was $0 and $58, respectively.

A summary of the status of the restricted shares granted under the DCP is presented below:


	Restricted Shares
Outstanding at December 31, 2025		3,548
Granted		1,172
Vested		—
Outstanding at June 30, 2026		4,720